Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria | Zendy

Garba Iliyasu | Zendy; AminuBashir Mohammad | Zendy; AbdulrazaqGarba Habib | Zendy

Open Access

Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria

Author(s) -

Garba Iliyasu,

AminuBashir Mohammad,

AbdulrazaqGarba Habib

Publication year - 2017

Publication title -

international journal of mycobacteriology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.53

H-Index - 20

eISSN - 2212-554X

pISSN - 2212-5531

DOI - 10.4103/2212-5531.201883

Subject(s) - rpob , medicine , tuberculosis , inha , mycobacterium tuberculosis , rifampicin , isoniazid , sputum , drug resistance , streptomycin , antibiotics , pathology , microbiology and biotechnology , biology

Drug-resistant tuberculosis (DR-TB) continues to be a challenge in developing countries with poor resources. Despite the high prevalence of primary DR-TB, its routine screening prior to the treatment is not performed in public hospitals in Nigeria. Data regarding drug resistance and its genetic determinant among follow-up patients with TB are lacking in Nigeria. Hence, the aim of this study was to determine the prevalence and genetic determinant of drug resistance among the follow-up patients with TB in a tertiary hospital in Nigeria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research